Tag: generic drug patent litigation
- 10/Nov/2025
- by William Womack
-
generic drug patent litigation
Hatch-Waxman Act
Orange Book patents
pay-for-delay settlements
Paragraph IV certification
Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines
Patent litigation in generic drug markets is delaying affordable medicines. Learn how the Hatch-Waxman Act, Orange Book listings, and serial lawsuits are shaping access to generics-and what’s being done to fix it.
ReadLatest Posts
